Viewing Study NCT03161132


Ignite Creation Date: 2025-12-24 @ 9:58 PM
Ignite Modification Date: 2026-04-14 @ 2:04 PM
Study NCT ID: NCT03161132
Status: COMPLETED
Last Update Posted: 2023-01-27
First Post: 2017-05-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Resistant Ovarian Cancer, Olaparib and Liposomal Doxorubicin
Sponsor: Grupo Español de Investigación en Cáncer de Ovario
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module